Product NDC: | 0409-4346 |
Proprietary Name: | Aminocaproic Acid |
Non Proprietary Name: | AMINOCAPROIC ACID |
Active Ingredient(s): | 250 mg/mL & nbsp; AMINOCAPROIC ACID |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4346 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070010 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110816 |
Package NDC: | 0409-4346-73 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4346-73) > 20 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-4346-73 |
Proprietary Name | Aminocaproic Acid |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4346-73) > 20 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-4346 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AMINOCAPROIC ACID |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110816 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | AMINOCAPROIC ACID |
Strength Number | 250 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |